Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,390 | 24,410 | 23,090 | 12,820 | 13,800 |
| Marketable Securities | 1,570 | 1,670 | 1,660 | 1,840 | 1,860 |
| Receivables | 40 | 40 | 30 | 170 | 70 |
| Other current assets | 370 | 490 | 220 | 260 | 390 |
| TOTAL | $23,370 | $26,610 | $25,000 | $15,090 | $16,120 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1,390 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $1,390 | $N/A |
| Total Assets | $23,710 | $26,990 | $25,410 | $15,570 | $16,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,500 | 2,480 | 3,450 | 3,050 | 3,030 |
| TOTAL | $2,500 | $2,480 | $3,450 | $3,050 | $3,030 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,500 | $2,480 | $3,450 | $3,050 | $3,030 |
| Shareholders' Equity | |||||
| Common Shares | 199,840 | 212,310 | 205,430 | 215,290 | 216,090 |
| Retained earnings | -199,040 | -209,340 | -204,860 | -226,440 | -226,340 |
| Other shareholders' equity | 490 | 370 | 400 | 250 | 170 |
| TOTAL | $21,200 | $24,500 | $21,950 | $12,510 | $13,580 |
| Total Liabilities And Equity | $23,700 | $26,980 | $25,400 | $15,560 | $16,610 |